aid: charmtherapeutics

name: Charmtherapeutics

description: 'Charm Therapeutics Ltd is a biotechnology company focused on developing next‑generation menin inhibitors to treat acute myeloid leukemia (AML) and other cancers. Leveraging advanced AI‑driven drug discovery, the team aims to overcome resistance seen with first‑generation menin inhibitors, delivering durable clinical outcomes. Based in London and Cambridge, the company collaborates with leading academic and industry partners to advance its pipeline through pre‑clinical and clinical stages.'

url: https://raw.githubusercontent.com/api-evangelist/charmtherapeutics/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-08 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-08'

modified: '2026-10-08'

tags:
- Company

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/charmtherapeutics-hosts.yml
- type: DomainSecurity
  url: security/charmtherapeutics-domain-security.yml
- type: Website
  url: https://charmtx.com

apis: []

x-coverage:
  state: blocked
  reason: bot-challenge
  method: derived
  generated: '2026-10-08'
  generator: derive-coverage.py (pre-flight evidence)
  detail: >-
    the company's own front door answers a browser with an anti-bot challenge, so nothing behind it is reachable by any reader
  evidence:
  - url: https://charmtx.com/mcp
    status: 403
  - url: https://charmtx.com
    status: 403
  - url: https://equityzen.com/company/charmtherapeutics
    status: 403
x-enrichment:
  date: '2026-10-08'
  status: enriched
  artifacts_added: 6
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local